Intervet gets first canine insulin; product slated for 2005 launch
MILLSBORO, DEL-Intervet received Food and Drug Administration (FDA) approval for the first canine insulin to treat diabetic dogs, Vetsulin.
MILLSBORO, DEL-Intervet received Food and Drug Administration (FDA) approval for the first canine insulin to treat diabetic dogs, Vetsulin.
The approval was announced at presstime, and the company reports the formal product launch is slated for 2005 due to worldwide demand, Dr. Karen Duncan, senior technical services specialist for Intervet tells DVM Newsmagazine.
Vetsulin is a porcine insulin zinc suspension used to improve the clinical signs of diabetes in dogs. Clinical signs include excessive thirst, urination and appetite, and weight loss despite good appetite. The prescription product has already been approved in 25 countries including the United Kingdom.
FDA reports that veterinarians determine the initial treatment dose based on a dog's weight and then use various tests to determine the optimum dosage. Maintenance administration of the insulin may be done by pet owners at home, FDA reports.
For fastest response, call
( 800 ) 441 - 8272
